Press Releases Items Per Page 102550 Year None202020192018201720162015201420132012201120102009200820072006 Date Title 3/31/20 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2/28/20 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2/27/20 Sarepta Therapeutics Announces Third Year of Route 79, The Duchenne Scholarship Program 2/26/20 Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Developments 2/19/20 Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Developments on February 26, 2020 1/31/20 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 1/13/20 Sarepta Therapeutics Appoints Renowned Biotech Executive John C. Martin to its Board of Directors 1/6/20 Sarepta Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 Year None202020192018201720162015201420132012201120102009200820072006 Date Title 3/31/20 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2/28/20 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2/27/20 Sarepta Therapeutics Announces Third Year of Route 79, The Duchenne Scholarship Program 2/26/20 Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Developments 2/19/20 Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Developments on February 26, 2020 1/31/20 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 1/13/20 Sarepta Therapeutics Appoints Renowned Biotech Executive John C. Martin to its Board of Directors 1/6/20 Sarepta Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
